BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: A systematic review

Heart Failure Reviews

Volumn 19, Issue 4, 2014, Pages 453-470

  Santaguida, Pasqualina L ^a   Don Wauchope, Andrew C ^a   Oremus, Mark ^a   McKelvie, Robert ^a   Ali, Usman ^a   Hill, Stephen A ^a   Balion, Cynthia ^a   Booth, Ronald A ^b   Brown, Judy A ^a   Bustamam, Amy ^a   Sohel, Nazmul ^a   Raina, Parminder ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Acute decompensated heart failure; BNP; NT proBNP; Prognosis; Systematic review

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACUTE HEART FAILURE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL DECISION MAKING; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MORBIDITY; OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN DETERMINATION; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; BLOOD; HEALTH; HEART FAILURE; SURVIVAL RATE;

GLOBAL HEALTH; HEART FAILURE; HUMANS; MORBIDITY; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; SURVIVAL RATE;

EID: 84906345383     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-014-9442-y     Document Type: Review

References (90)

1. Balion C, Santaguida PL, Hill S, Worster A, McQueen M, Oremus M, McKelvie R, Booker L, Fagbemi J, Reichert S, Raina P (2006) Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure. AHRQ, Rockville. AHRQ Publication No. 06-E014
2. Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D et al (2009) B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circ Cardiovasc Qual Outcomes 120:2177-2187. doi:10.1161/CIRCULATIONAHA.109.884866
3. Doust JA, Pietrzak E, Dobson A, Glasziou P (2005) How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330:625. doi:10.1136/bmj.330.7492.62
4. Vesbianu D, Vesbianu C, Bernstein P, Kouides R (2008) Plasma brain natriuretic peptide - an independent predictor of mortality and rehospitalization in congestive heart failure - a meta-analysis. World Heart J 1:349-354
5. Oremus M, Raina PS, Santaguida P, Balion CM, McQueen MJ, McKelvie R et al (2008) A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease. Clin Biochem 41:260-265. doi:10.1016/j.clinbiochem. 2007.09.011 (Pubitemid 351240898)
6. Avellino A, Collins SP, Fermann GJ (2011) Risk stratification and short-term prognosis in acute heart failure syndromes: a review of novel biomarkers. Biomarkers 16:379-392. doi:10.3109/1354750X.2011.574234
7. Methods guide for effectiveness and comparative effectiveness reviews (2014). Agency for Healthcare Research and Quality, Rockville. AHRQ Publication No. 10(14)-EHC063-EF. http://www.effectivehealthcare.ahrq.gov/search-for-guides- reviews-andreports/?pageaction=displayproduct&mp=1&productID=318
8. Hayden JA, Côté P, Bombardier C (2006) Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 144:427-437. doi:10.7326/0003-4819-144-6-200603210-00010 (Pubitemid 46768164)
9. Law KK, Yau WH, Ho HF (2010) Short-term prognostic value of the rapid b-type natriuretic peptide assay on length of hospitalisation in congestive heart failure patients presenting to an emergency department in Hong Kong: a prospective observational study. Hong Kong J Emerg Med 17:451-463
10. Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, Green G et al (2004) Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 44:1328-1333. doi:10.1016/j.jacc.2004.06.015 (Pubitemid 39208893)
11. Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F et al (2004) Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43:635-641. doi:10.1016/j.jacc.2003.09.044 (Pubitemid 38229537)
12. Aspromonte N, Feola M, Milli M, Scardovi AB, Coletta C, Carbonieri E et al (2007) Prognostic role of B-type natriuretic peptide in patients with diabetes and acute decompensated heart failure. Diabet Med 24:124-130. doi:10.1111/j.1464-5491.2007.02070.x (Pubitemid 46174934)
13. Stoiser B, Mörtl D, Hulsmann M, Berger R, Struck J, Morgenthaler NG et al (2006) Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eur J Clin Invest 36:771-778. doi:10.1111/j.1365-2362.2006.01724.x (Pubitemid 44569965)
14. Cournot M, Leprince P, Destrac S, Ferriéres J (2007) Usefulness of in-hospital change in B-type natriuretic peptide levels in predicting long-term outcome in elderly patients admitted for decompensated heart failure. Am J Geriatr Cardiol 16:8-14. doi:10.1111/j.1076-7460.2007.05297.x
15. Sun T, Wang L, Zhang Y (2007) Prognostic value of B-type natriuretic peptide in patients with chronic and advanced heart failure. Intern Med J 37:168-171. doi:10.1111/j.1445-5994.2006.01296.x
16. Gegenhuber A, Struck J, Dieplinger B, Poelz W, Pacher R, Morgenthaler NG et al (2007) Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. J Card Fail 13:42-49. doi:10.1016/j.cardfail.2006.09.004 (Pubitemid 46343794)
17. Kellett J (2006) Prediction of mortality of patients with suspected heart failure by brain natriuretic peptide concentrations > 100 pg/ml: comparison of a clinical model with brain natriuretic peptide concentrations. Heart 92:1512-1513. doi:10.1136/hrt.2005.069286
18. Valle R, Aspromonte N, Feola M, Milli M, Canali C, Giovinazzo P et al (2005) B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function. J Card Fail 11:498-503. doi:10.1016/j.cardfail.2005.05.002 (Pubitemid 41403272)
19. Dokainish H, Zoghbi WA, Lakkis NM, Ambriz E, Patel R, Quinones MA et al (2005) Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 45:1223-1226. doi:10.1016/j.jacc.2005.01.025 (Pubitemid 40523141)
20. Di Somma S, Magrini L, Pittoni V, Marino R, Mastrantuono A, Ferri E et al (2010) In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study. Crit Care 14:R116. doi:10.1186/cc9067
21. Zairis MN, Tsiaousis GZ, Georgilas AT, Makrygiannis SS, Adamopoulou EN, Handanis SM et al (2010) Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure. Int J Cardiol 141:284-290. doi:10.1016/j.ijcard.2008.12.017
22. Reichlin T, Socrates T, Egli P, Potocki M, Breidthardt T, Arenja N et al (2010) Use of myeloperoxidase for risk stratification in acute heart failure. Clin Chem 56:944-951. doi:10.1373/clinchem.2009.142257
23. Nahum J, Bensaid A, Dussault C, Macron L, Clemence D, Bouhemad B et al (2010) Impact of longitudinal myocardial deformation on the prognosis of chronic heart failure patients. Circ Heart Fail 3:249-256. doi:10.1161/?CIRCIMAGING. 109.910893
24. Faggiano P, Valle R, Aspromonte N, D'Aloia A, Di Tano G, Barro S et al (2010) How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification. Int J Cardiol 140:88-94. doi:10.1016/j.ijcard.2008.11.020
25. Farmakis D, Parissis JT, Bistola V, Paraskevaidis IA, Iliodromitis EK, Filippatos G et al (2010) Plasma B-type natriuretic peptide reduction predicts long-term response to levosimendan therapy in acutely decompensated chronic heart failure. Int J Cardiol 139:75-79. doi:10.1016/j.ijcard.2008.10.003
26. Neuhold S, Huelsmann M, Strunk G, Struck J, Adlbrecht C, Gouya G et al (2010) Prognostic value of emerging neurohormones in chronic heart failure during optimization of heart failure-specific therapy. Clin Chem 56:121-126. doi:10.1373/clinchem.2009.125856
27. Dunlay SM, Gerber Y, Weston SA, Killian JM, Redfield MM, Roger VL (2009) Prognostic value of biomarkers in heart failure: application of novel methods in the community. Circ Heart Fail 2:393-400. doi:10.1161/CIRCHEARTFAILURE.109. 849299
28. Singer AJ, Birkhahn RH, Guss D, Chandra A, Miller CD, Tiffany B et al (2009) Rapid Emergency Department Heart Failure Outpatients Trial (REDHOT II): a randomized controlled trial of the effect of serial B-type natriuretic peptide testing on patient management. Circ Heart Fail 2:287-293. doi:10.1161/ CIRCHEARTFAILURE.108.826685
29. Parissis JT, Farmakis D, Nikolaou M, Birmpa D, Bistola V, Paraskevaidis I et al (2009) Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: a 1-year follow-up study. Eur J Heart Fail 11:967-972. doi:10.1093/eurjhf/hfp125
30. Cohen-Solal A, Logeart D, Huang B, Cai D, Nieminen MS, Mebazaa A (2009) Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. J Am Coll Cardiol 53:2343-2348. doi:10.1016/j.jacc.2009.02.058
31. Dhaliwal AS, Deswal A, Pritchett A, Aguilar D, Kar B, Souchek J et al (2009) Reduction in BNP levels with treatment of decompensated heart failure and future clinical events. J Card Fail 15:293-299. doi:10.1016/j.cardfail.2008
32. Núñez J, Núñez E, Robles R, Bodi V, Sanchis J, Carratalá A et al (2008) Prognostic value of brain natriuretic peptide in acute heart failure: mortality and hospital readmission. Rev Esp Cardiol 61:1332-1337. doi:10.1016/S1885-5857(09)60062-1
33. Feola M, Aspromonte N, Milani L, Bobbio M, Bardellotto S, Barro S et al (2008) Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern. J Card Fail 14:420-425. doi:10.1016/j.cardfail.2008.01.013 (Pubitemid 351749837)
34. Cournot M, Mourre F, Castel F, Ferriéres J, Destrac S (2008) Optimization of the use of B-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure. Am Heart J 155:986-991. doi:10.1016/j.ahj.2008.01.011
35. Valle R, Aspromonte N, Carbonieri E, D'Eri A, Feola M, Giovinazzo P et al (2008) Fall in readmission rate for heart failure after implementation of B-type natriuretic peptide testing for discharge decision: a retrospective study. Int J Cardiol 126:400-406. doi:10.1016/j.ijcard.2006.03.097 (Pubitemid 351636361)
36. Parissis JT, Nikolaou M, Farmakis D, Bistola V, Paraskevaidis IA, Adamopoulos S et al (2008) Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure. Heart 94:585-589. doi:10.1136/hrt.2007.117390 (Pubitemid 351580132)
37. Valle R, Aspromonte N, Giovinazzo P, Carbonieri E, Chiatto M, Di Tano G et al (2008) B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in subintensive care unit with acute heart failure. J Card Fail 14:219-224. doi:10.1016/j.cardfail.2007.10.009 (Pubitemid 351444865)
38. Dieplinger B, Gegenhuber A, Poelz W, Haltmayer M, Mueller T (2009) Prognostic value of increased adiponectin plasma concentrations in patients with acute destabilized heart failure. Clin Biochem 42:1190-1193. doi:10.1016/j.clinbiochem.2009.02.023
39. Núñez J, Sanchis J, Bodi V, Fonarow GC, Núñez E, Bertomeu-Gonzalez V et al (2010) Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure. Eur Heart J 31:1752-1763. doi:10.1093/eurheartj/ehq142
40. Pimenta J, Paulo C, Mascarenhas J, Gomes A, Azevedo A, Rocha-Gonçalves F et al (2010) BNP at discharge in acute heart failure patients: is it all about volemia? A study using impedance cardiography to assess fluid and hemodynamic status. Int J Cardiol 145:209-214. doi:10.1016/j.ijcard.2009.08.001
41. Xue Y, Clopton P, Peacock WF, Maisel AS (2011) Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure. Eur J Heart Fail 13:37-42. doi:10.1093/eurjhf/hfq210
42. Rychli K, Richter B, Hohensinner PJ, Kariem Mahdy A, Neuhold S, Zorn G et al (2011) Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure. Heart 97:1158-1163. doi:10.1136/hrt.2010. 220228
43. Arques SR (2011) Usefulness of serum albumin and serum total cholesterol in the prediction of hospital death in older patients with severe, acute heart failure. Arch Cardiovasc Dis 104:502-508. doi:10.1016/j.acvd.2011.06.003
44. Allen LA, Gheorghiade M, Reid KJ, Dunlay SM, Chan PS, Hauptman PJ et al (2011) Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes 4:389-398. doi:10.1161/CIRCOUTCOMES.110.958009
45. Coyne JC, Jaarsma T, Luttik ML, van Sonderen E, van Veldhuisen DJ, Sanderman R (2011) Lack of prognostic value of type D personality for mortality in a large sample of heart failure patients. PsychosomMed 73:557-562. doi:10.1097/PSY.0b013e318227ac75
46. Maisel AS, Mueller C, Fitzgerald R, Brikhan R, Hiestand BC, Iqbal N et al (2011) Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail 13:846-851. doi:10.1093/eurjhf/hfr087
47. Arenja N, Reichlin T, Drexler B, Oshima S, Denhaerynck K, Haaf P et al (2012) Sensitive cardiac troponin in the diagnosis and risk stratification of acute heart failure. J Intern Med 271:598-607. doi:10.1111/j.1365-2796.2011. 02469.x
48. Sakhuja R, Green S, Oestreicher EM, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB et al (2007) Amino-terminal probrain natriuretic peptide, brain natriuretic peptide, and troponin T for prediction of mortality in acute heart failure. Clin Chem 53:412-420. doi:10.1373/clinchem.2006.074047 (Pubitemid 46447937)
49. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P et al (2010) Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 55:2062-2076. doi:10.1016/j.jacc.2010.02.025
50. Boisot S, Beede J, Isakson S, Chiu A, Clopton P, Januzzi J et al (2008) Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure. J Card Fail 14:732-738. doi:10.1016/j.cardfail.2008.06.415
51. Noveanu M, Breidthardt T, Potocki M, Reichlin T, Twerenbold R, Uthoff H et al (2011) Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of shortand long-term outcome in acute decompensated heart failure. Crit Care 15:R1. doi:10.1186/cc9398
52. Rehman SU, Mueller T, Januzzi J (2008) Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol 52:1458-1465. doi:10.1016/j.jacc.2008.07.042
53. Peacock WF, Nowak R, Christenson R, DiSomma S, Neath SX, Hartmann O et al (2011) Short-term mortality risk in emergency department acute heart failure. Acad Emerg Med 18:947-958. doi:10.1111/j.1553-2712.2011.01150.x
54. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A (2004) N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circ Cardiovasc Qual Outcomes 110:2168-2174. doi:10.1161/01.CIR.0000144310.04433.BE (Pubitemid 39372496)
55. Baggish AL, van Kimmenade R, Bayes-Genis A, Davis M, Lainchbury JG, Frampton C et al (2007) Hemoglobin and N-terminal pro-brain natriuretic peptide: independent and synergistic predictors of mortality in patients with acute heart failure results from the International Collaborative of NT-proBNP (ICON) Study. Clin Chim Acta 381:145-150. doi:10.1016/j.cca.2007.03.010 (Pubitemid 46719148)
56. Bettencourt P, Azevedo A, Fonseca L, Araujo JP, Ferreira S, Almeida R et al (2007) Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NTproBNP variations during hospitalization. Int J Cardiol 117:75-79. doi:10.1016/j.ijcard.2006.06.004 (Pubitemid 46399972)
57. Perna ER, Macin SM, Cimbaro Canella JP, Szyszko A, Franciosi V, Vargas MW et al (2006) Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure. J Heart Lung Transpl 25:1230-1240. doi:10.1016/j.healun.2006.08.004 (Pubitemid 44528293)
58. van Kimmenade RR, Januzzi JL Jr, Baggish AL, Lainchbury JG, Bayes-Genis A, Richards AM et al (2006) Amino-terminal probrain natriuretic peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction? J Am Coll Cardiol 48:1621-1627. doi:10.1016/j.jacc.2006.06.056 (Pubitemid 44528169)
59. van Kimmenade RR, Januzzi JL Jr, Ellinor PT, Sharma UC, Bakker JA, Low AF et al (2006) Utility of amino-terminal probrain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol 48:1217-1224. doi:10.1016/j.jacc.2006.03.061 (Pubitemid 44345127)
60. Marcucci R, Gori AM, Giannotti F, Baldi M, Verdiani V, Del Pace S et al (2006) Markers of hypercoagulability and inflammation predict mortality in patients with heart failure. J Thromb Haemostasis 4:1017-1022. doi:10.1111/j.1538-7836.2006.01916.x
61. Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordóñnez-Llanos J, Santalo-Bel M et al (2006) NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27:330-337. doi:10.1093/eurheartj/ehi631 (Pubitemid 43100029)
62. Bayés-Genis A, Lopez L, Zapico E, Cotes C, Santaló M, Ordóñnez-Llanos J et al (2005) NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality. J Card Fail 11:S3-S8. doi:10.1016/j.cardfail.2005.04. 006
63. Bayes-Genis A, Pascual-Figal D, Fabregat J, Domingo M, Planas F, Casas T et al (2007) Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure. Int J Cardiol 120:338-343. doi:10.1016/j. ijcard.2006.10.009 (Pubitemid 47069559)
64. Ferreira S, Almeida R, Guerrero H, Lourenco-Ferreira S, Fonseca L, Rocha R et al (2007) Prognosis of decompensated heart failure: role of NT-proBNP. Rev Port Cardiol 26:535-545 (Pubitemid 47067555)
65. Pimenta JM, Almeida R, Araújo JP, Azevedo A, Friões F, Rocha-Gonçalves F et al (2007) Amino terminal B-type natriuretic peptide, renal function, and prognosis in acute heart failure: a hospital cohort study. J Card Fail 13:275-280. doi:10.1016/j.cardfail.2007.01.001 (Pubitemid 46756339)
66. Siswanto BB, Sunanto Munawar M, Kusmana D, Hanafiah A, Waspadji S et al (2006) Predictor of mortality and rehospitalization of acute decompensated heart failure at six months follow up. Crit Care Shock 9:61-67 (Pubitemid 44336247)
67. Park HS, Kim H, Sohn JH, Shin HW, Cho YK, Yoon HJ et al (2010) Combination of uric acid and NT-ProBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failure. Korean J Intern Med 25:253-259. doi:10.3904/kjim.2010.25.3.253
68. Davutoglu V, Yildirim C, Kucukaslan H, Yuce M, Sari I, Tarakcioglu M et al (2010) Prognostic value of pleural effusion, CA-125 and NT-proBNP in patients with acute decompensated heart failure. Kardiol Pol 68:771-778
69. Dini FL, Buralli S, Bajraktari G, Elezi S, Duranti E, Metelli MR et al (2010) Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease. Biomed Pharmacother 64:339-342. doi:10.1016/j.biopha.2009.09.008
70. Mohammed AA, van Kimmenade RR, Richards M, Bayes-Genis A, Pinto Y, Moore SA et al (2010) Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study. Circ Heart Fail 3:354-361. doi:10.1161/CIRCHEARTFAILURE.109. 915280
71. Baggish AL, van Kimmenade RR, Pinto Y, Richards AM, Lainchbury J, Bayes-Genis A et al (2010) New York Heart Association class versus amino-terminal pro-B-type natriuretic peptide for acute heart failure prognosis. Biomarkers 15:307-314. doi:10.3109/13547501003632580
72. Lourenco P, Azevedo A, Araújo JP, Bettencourt P (2009) Natriuretic peptide system is not exhausted in severe heart failure. J Cardiovasc Med (Hagerstown) 10:39-43. doi:10.2459/JCM.0b013e328319679f
73. Manzano-Fernández S, Boronat-Garcia M, Albaladejo-Otón MD, Pastor P, Garrido IP, Pastor-Pérez FJ et al (2009) Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Am J Cardiol 103:1753-1759. doi:10.1016/j.amjcard.2009.02.029
74. Kubler P, Jankowska EA, Majda J, Reczuch K, Banasiak W, Ponikowski P (2008) Lack of decrease in plasma N-terminal probrain natriuretic peptide identifies acute heart failure patients with very poor outcome. Int J Cardiol 129:373-378. doi:10.1016/j.ijcard.2007.07.126
75. Paul B, Soon KH, Dunne J, De Pasquale CG (2008) Diagnostic and prognostic significance of plasma N-terminal-pro-brain natriuretic peptide in decompensated heart failure with preserved ejection fraction. Heart Lung Circ 17:497-501. doi:10.1016/j.hlc.2008.06.001
76. Verdiani V, Ognibene A, Rutili MS, Lombardo C, Bacci F, Terreni A et al (2008) NT-ProBNP reduction percentage during hospital stay predicts long-term mortality and readmission in heart failure patients. J Cardiovasc Med (Hagerstown) 9:694-699. doi:10.2459/JCM.0b013e3282f447ae
77. Andersson SE, Edvinsson ML, Bjõrk J, Edvinsson L (2008) High NT-proBNP is a strong predictor of outcome in elderly heart failure patients. Am J Geriatr Cardiol 17:13-20. doi:10.1111/j.1076-7460.2007.06674.x
78. Petretta M, Scopacasa F, Fontanella L, Carlomagno A, Baldissara M, de Simone A et al (2007) Prognostic value of reduced kidney function and anemia in patients with chronic heart failure. J Cardiovasc Med (Hagerstown) 8:909-916. doi:10.2459/JCM.0b013e32801464b6 (Pubitemid 47517734)
79. Metra M, Nodari S, Parrinello G, Specchia C, Brentana L, Rocca P et al (2007) The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. Eur J Heart Fail 9:776-786.doi:10.1016/j.ejheart.2007.05.007 (Pubitemid 47212835)
80. Lassus J, Harjola VP, Sund R, Siirila-Waris K, Melin J, Peuhkurinen K et al (2007) Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. Eur Heart J 28:1841-1847. doi:10.1093/eurheartj/ehl507 (Pubitemid 47236639)
81. Lüers C, Schmidt A, Wachter R, Fritzsche F, Sutcliffe A, Kleta S et al (2010) Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure. Herz 35:488-496. doi:10.1007/s00059-010-3377-4
82. Carrasco-Sánchez FJ, Galisteo-Almeda L, Páez-Rubio I, Martinez-Marcos FJ, Camacho-Vazquez C, Ruiz-Frutos C et al (2011) Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction. J Card Fail 17:31-38. doi:10.1016/j.cardfail.2010.07.248
83. Pascual-Figal DA, Manzano-Fernández S, Boronat M, Casas T, Garrido IP, Bonaque JC et al (2011) Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail 13:718-725. doi:10.1093/eurjhf/hfr047
84. Ho SJ, Feng AN, Lee LN, Chen JW, Lin SJ (2011) Predictive value of predischarge spectral tissue doppler echocardiography and n-terminal pro-B-type natriuretic peptide in patients hospitalized with acute heart failure. Echocardiography 28:303-310. doi:10.1111/j.1540-8175.2010.01322.x
85. Michtalik HJ, Yeh HC, Campbell CY, Haq N, Park H, Clarke W et al (2011) Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure. Am J Cardiol 107:1191-1195. doi:10.1016/j.amjcard.2010.12.018
86. Korewicki J, Leszek P, Zielinski T, Rywik T, Piotrowski W, Kurjata P et al (2012) Severe chronic heart failure in patients considered for heart transplantation in Poland. Cardiol J 19:36-44. doi:10.5603/CJ.2012.0007
87. Krackhardt F, Düngen HD, Trippel TD, Inkrot S, Tscholl V, Schlattmann P et al (2011) N-terminal pro-B-type natriuretic peptide and long-term mortality in non-ischemic cardiomyopathy. Wien Klin Wochenschr 123:738-742. doi:10.1007/s00508-011-0092-y
88. Harutyunyan M, Christiansen M, Johansen JS, Køber L, Torp-Petersen C, Kastrup J (2012) The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure. Immunobiology 217:652-656. doi:10.1016/j.imbio.2011.11.003
89. Kalil AC, Mattei J, Florescu DF, Sun J, Kalil RS (2010) Recommendations for the assessment and reporting of multivariable logistic regression in the transplantation literature. Am J Transpl 10:1686-1694. doi:10.1111/j.1600-6143. 2010.03141.x
90. Centre for Reviews and Dissemination. Systematic reviews: CRD's guidance for undertaking reviews in health care. York, UK: CRD, University of York; 2009. http://www.york.ac.uk/inst/crd/pdf/Systematic-Reviews.pdf